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 
Abstract—Goal: The HF-CGM is a proof-of-principle study to 
investigate whether cardiogoniometry (CGM), a three-
dimensional electrocardiographic method, can differentiate 
between pacing modes in patients with cardiac resynchronisation 
therapy (CRT). Methods: At a tertiary cardiology centre, CGM 
recordings were performed using four pacing modes: no pacing; 
right ventricular (RV) pacing; left ventricular (LV) pacing and 
biventricular (BIV) pacing.  Three orthogonal CGM planes 
orientated to the long axis (XY), the frontal plane (YZ) and the 
short axis (XZ) of the heart were constructed, and the direction of 
the QRS axis was calculated for each pacing mode in each plane. 
During BIV pacing, the direction of CGM QRS axis was compared 
between patients with optimal and non-optimal 12-lead pacing 
variables.  Results: Twenty-two participants (aged 71.5±10.8; 
77.3% male, LVEF 29±7%) were consecutively recruited. Only 
QRS axis measured in the XY plane could significantly distinguish 
between all three pacing modes vs. no pacing. Mean QRS axis in 
the XY plane with pacing off and during RV pacing was leftwards 
and basal; LV pacing was apical; and BIV pacing was rightwards 
and basal. There was a statistically significant difference in the 
direction of QRS axis between patients with optimal vs. non-
optimal paced QRS morphology in the XY plane (rightwards and 
basal vs. inconsistent). Significance: CGM recorded in the XY 
plane can accurately detect differences between ventricular pacing 
sites. It may also be able to identify patients with a CRT device in 
situ who have optimal response. 
   
 
Index Terms— Cardiac axis, Cardiac Resynchronization 
therapy, Cardiogoniometry, Heart Failure  
 
I. INTRODUCTION 
 ardiac resynchronization therapy (CRT) improves both the 
symptoms and the prognosis of patients with chronic heart 
failure [1], and is indicated in people with heart failure and left 
bundle branch block (LBBB). 
Unfortunately, approximately 25% of patients do not gain 
significant clinical benefit with CRT [2]. Such patients are 
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termed “non-responders”, and lack of response is typically 
measured as a failure to improve exercise capacity with CRT, 
or a failure of left ventricular function to improve on 
echocardiography. Many methods have been proposed to 
improve response to CRT, but no specific technique has been 
shown to be superior to another and the long term clinical 
benefit of each technique is unclear [3]. 
Cardiogoniometry (CGM) is a method of 
vectorcardiographic (VCG) assessment [4][5]. The Cardiologic 
Explorer (Enverdis GmBH, Jena, Germany) is the only 
commercially available device. It uses five electrodes arranged 
to make a recording from three virtual bipolar leads (see Fig. I). 
Three orthogonal planes can be constructed from the bipolar 
leads and are approximately orientated to the long axis (XY) of 
the heart, the frontal plane (YZ) and the short axis (XZ) of the 
heart (see Fig. II). A heart vector can be plotted in each plane 
over time, resulting in vector loops in three dimensions for the 
P, QRS and T waves. The introduction of quadripolar leads and 
multipoint pacing have made it possible to alter CRT LV pacing 
site at follow-up to achieve better response. This optimisation 
is routinely done using ECG. Similar to ECG, CGM is a non-
invasive, quick method that can be used at the bedside. 
However, CGM has greater three-dimensional resolution and 
CGM-guided optimisation of CRT may be superior to that using 
ECG, leading to better patient outcomes. 
Previous work using CGM has been limited to investigating 
its diagnostic performance in patients with suspected coronary 
artery disease [6][7]. However, the effect of CRT on QRS axis 
has not been formally described. Interestingly, recent work with 
other methods of VCG has indicated that VCG can help 
improve response to CRT [8–10]. Furthermore, the direction of 
cardiac electrical activity after CRT implantation also predicts 
improvement in left ventricular ejection fraction (LVEF) [11] 
[12].  
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of CGM derived QRS axis to detect changes in CRT pacing site. 
II. METHODOLOGY 
A. Study participants 
Twenty-two patients undergoing routine CRT device checks 
were recruited between November 2015 and November 2016. 
During implantation the right ventricular lead was placed in 
either the apical or low septal position. Positioning of the left 
ventricular lead was guided by coronary sinus venography to 
the lateral or posterolateral region. In one case, this was not 
technically possible and the lead was deployed in the great 
cardiac vein.  For inclusion, patients had to be aged 18 or over, 
have a functioning CRT device implanted and be able to 
provide informed written consent. Patients who were 
pacemaker dependent (i.e. had no intrinsic electrical activity) 
and non-English speakers were excluded from the study. 
B. Ethics 
 
The study protocol along with all other documentation was 
approved by the regional ethics committee (15/NW/0479 and 
16/YH/0185). The study was registered on 
http://www.clinicaltrials.gov/, unique identifier: 
NCT02803879 and  NCT02748876. We conducted our study in 
compliance with the principles of the Declaration of Helsinki. 
 
C. Study Protocol  
 
Four CGM electrodes were placed on the patient’s thorax, 
with a fifth CGM electrode placed on the patient’s left thigh to 
act as a grounding electrode. Eleven patient underwent the 
following sequential CGM recordings whilst lying as still as 
possible whilst the recording was in progress: (1) biventricular 
pacing (BIV) with no changes in device settings; (2) pacing via 
the RV lead alone; (3) pacing via the LV lead alone; and (4) 
both RV and LV leads turned off. Another eleven patients had 
BiV and off pacing recordings only. All recording were 
obtained with patients breath-holding at peak inspiration. For 
paced rhythms, traces were obtained at a minimum paced rate 
of 80 bpm (or until intrinsic electrical activity had been 
overcome) so the recordings taken were a reflection of paced 
cardiac axis and not intrinsic electrical activity. Atrioventricular 
conduction was intrinsic or set to default delay settings.  
12-lead ECGs were also recorded to allow comparisons of 
mean frontal cardiac axis calculated by both methods. The limb 
electrodes for the 12-lead ECG were placed on the patient’s 
wrists and ankles, precordial electrodes were placed in Wilson 
positions V1 to V6 [13]. Finally, patients had their CRT settings 
restored (or optimised using conventional methods if clinically 
indicated).  
 
D. Data analysis 
CGM data were recorded using the Patient Explorer software 
version 2.1 [Enverdis, Jena, Germany]. For each of the CGM 
recordings, the mean QRS axis (in degrees) was calculated as 
follows: the net deflection of the QRS complex (mV) was 
measured for each of the X, Y and Z axes to produce orthogonal 
coordinates. Polar angles for the XY, YZ, and XZ planes were 
calculated using formulae previously described by Sanz et al in 
1983 [4] (Appendix 1.1 in the supplementary material). The 
mean frontal QRS axis was calculated from the 12 lead ECG. 
The net deflection of the QRS complex measured in the plane 
defined by the orthogonal leads I and aVF was used to produce 
coordinates, which were subsequently transformed to polar 
angles by trigonometry (Appendix 1.2 in the supplementary 
material). This method is validated for calculating the cardiac 
axis [14].  
Fig. 1. Principles of Cardiogoniometry. A: Showing electrode placement: 
electrode 1 (green), Wilson position V4; electrode 2 (white), Wilson position 
V8; electrode 3 (yellow), directly superior to electrode 1 at a distance 0.7 
times the distance between electrode 1 and 2; electrode 4 (red), directly right 
of electrode 3 at a distance the same as between electrode 1 and 3. The 
following leads are defined by the following electrodes: Anterior (A) by 
electrode 4→1; Horizontal (Ho) by electrode 4→3; Vertical (Ve) by 
electrode 3→1; Inferior by electrode 2→1 and Diagonal (D) by electrode 
4→2 (see figure 2A). Triangles left of the thorax show the direction of the 
aforementioned leads. B: Showing the orientation of orthogonal axes X, Y 
and Z in the thorax (left panel) and trigonometric equations defining their 
formation (right panel); C: Showing the formation of vector loops by plotting 
of the heart vector at every millisecond for the P (grey), QRS (blue) and T 
waves (green), with maximum vectors for the P and QRS loop (orange lines) 
being shown. Reproduced from Schupbach et al [6]. 
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The CGM YZ plane is claimed to be equivalent to the frontal 
plane calculated by the ECG rotated by -45, and so we 
subtracted 45° from the axis calculated from the conventional 
ECG to allow direct comparison with the axis calculated from 
CGM [4]. 
 
E. Statistical analysis 
 
IBM SPSS Statistics for Macintosh, Version 23.0 was used 
for statistical analysis of baseline clinical characteristics. 
Descriptive statistics were used to summarise the data. Baseline 
continuous variables are expressed as mean ±SD, categorical 
data are expressed as numbers/percentages. Statistical analysis 
for the axis data was performed using RStudio Version 0.99.491 
(RStudio Inc, Boston, USA). Values for the cardiac axis were 
first transformed from linear to circular format, with the scale 
in degrees going from 0180/-1800. The mean and 95% 
confidence interval (based on a Von Mises distribution) [15] for 
each CRT pacing site in each plane was calculated. Differences 
between pacing sites were assessed with the non-parametric 
Moore’s test for paired circular data, with RV pacing, LV 
pacing and biventricular pacing compared to no pacing. The 
equivalence of the frontal CGM plane to the conventional ECG 
plane was assessed by visual comparison of scatterplots. A 
secondary analysis was performed based on whether patients 
had satisfied the ‘optimal’ QRS morphology defined by Bode 
et al [11] (R/S ratio 1 in V1 and/or R/S ratio 1 in lead I) on 
their initial ECG with CRT. Statistical differences between 
‘optimal’ and ‘non-optimal’ groups were assessed with 
Watson’s non-parametric test and visual comparison of circular 
scatter plots. Statistical significance was pre-defined as p0.05.  
 
 
III. RESULTS 
 
Baseline characteristics for study participants are shown in 
Table. I. 
 
  
TABLE I 
BASELINE CHARACTERISTICS OF STUDY PARTICIPANTS 
Demographics 
 
N 22 
Male (%)  17 (77.3) 
Age (SD), years 71.5 (10.8) 
Body mass index (SD) 29.9 (5.9) 
NYHA class (I, II, III, IV) 4/7/11/0 
Ejection fraction (SD), % 28.7 (6.85) 
Ischaemic etiology (%) 11 (50.0) 
Native QRS duration (SD), ms 164 (12.5) 
Native QRS morphology (%)  
LBBB 21 (95.5) 
Non-LBBB 1 (4.5) 
Type of CRT device fitted (%):  
 Medtronic PROTECTA CRT-D 7 (31.8) 
 St Jude ANTHEM RF CRT-P 
St Jude  QUADRA ASSURA MP 
CRT-D 
 Biotronik ITREVIA 5 HF-T QP 
CRT-D 
St Jude QUADRA ALLURE MP 
CRT-P 
4 (18.2) 
6 (27.3) 
4 (18.2) 
1 (4.5) 
RV lead position (%):   
Apex 13 (59.1) 
Septum 9 (40.9) 
LV lead position (%):  
Left posterior ventricular vein 19 (86.4) 
Left marginal vein 2 (9.1) 
Great cardiac vein 1 (4.5) 
LV lead pace/sense configuration (%):  
Bipolar 6 (27.3) 
Quadripolar 16 (72.7) 
Length of CRT implantation (SD), 
months 
26.5 (11.6) 
Sensed AV delay (SD), ms 121 (26.8) 
Paced AV delay (SD), ms 160 (29) 
VV delay (SD), ms 22 (21) 
Past medical history (%)  
Myocardial infarction 9 (40.9) 
Percutaneous coronary intervention 11 (50.0) 
Atrial fibrillation 5 (22.7) 
Stroke/ Transient ischemic attack 5 (22.7) 
Chronic kidney disease 13 (59.1) 
Diabetes mellitus 12 (54.5) 
Hypertension 12 (54.5) 
Hypercholesterolaemia 14 (63.6) 
Smoking (Never/Ex/Current) 7 (31.8 / 14 (63.6) / 1 (4.5) 
Medications (%) 
Aspirin 8 (36.4) 
Clopidogrel 4 (18.2) 
ACEi 12 (54.5) 
ARB 8 (36.4) 
-blocker 20 (90.1) 
MRA 13 (59.1) 
Loop diuretic 19 (86.4) 
Digoxin 4 (18.2) 
Blood results (%) 
Haemoglobin, g/L 121.5 (12.0) 
Sodium, mmol/L 136.4 (3.6) 
Potassium, mmol/L 4.3 (0.3) 
Chloride, mmol/L 101.8 (6.2) 
Urea, mmol/L 17.5 (15.4) 
Creatinine, mol/L 100.2 (30.8) 
NT proBNP, ng/L 1277.5 (657.7) 
Continuous data are expressed as mean and standard deviation (SD). 
Abbreviations: angiotensin converting enzyme inhibitor (ACEi), angiotensin 
receptor blocker (ARB), atrioventricular (AV), Intraventricular (VV), left 
bundle branch block (LBBB), left ventricle (LV), mineralocorticoid receptor 
antagonist (MRA),    
 
 
 
 
Fig. 2. Cardiac CT images of one patient in the same approximate 
sections as the CGM planes -XY plane (panel A), YZ plane (panel B), 
XZ plane (panel C). Green shading represents the right ventricle; yellow 
shading represents the left ventricle. Images used with permission. 
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A. Direction of cardiac axis by pacing settings 
Mean angles and their 95% confidence interval for each 
device setting in each plane are shown in Table II. Biventricular 
pacing led to a very wide range of readings in all three planes. 
The narrowest ranges for axis were in the XY plane, and only 
in the XY plane were there significant differences in axis 
between all three different pacing modes compared to no pacing 
(Table III). There was a significant difference in axis in the XZ 
plane between no pacing and biventricular pacing, but not in the 
YZ plane. 
 
B. Mean QRS axis: ECG plane vs. CGM YZ plane 
There was little agreement in the direction of the cardiac 
axis between the YZ CGM plane and conventional ECG plane 
(Fig. 3). 
 
C. ‘Optimal’ QRS axis vs. non-optimal QRS axis morphology 
Fig. 4. shows scatter plots for patients with optimal vs. non-
optimal paced QRS morphology in each CGM plane. In the XY 
plane, the axis of patients with optimal paced QRS morphology 
was mostly directed between -90 to -180, towards the right 
basal side of the heart, whereas there was no consistency in the 
direction of axis in patients with a non-optimal paced QRS 
morphology. This difference in axis direction was statistically 
significant (p=0.005). In the other two planes, there was a large 
overlap in the direction of axis for participants with an optimal 
paced QRS morphology and non-optimal paced QRS 
morphology, with no consistent pattern in axis. 
 
IV. DISCUSSION 
We have found that different CRT device settings lead to 
differences in CGM recordings, and that the most consistent 
patterns are seen with recordings in the XY plane. We have also 
shown that the electrical axis recorded in the YZ plane using 
CGM is not the same as the mean frontal QRS axis recorded in 
the frontal plane of the ECG as previously thought, even after 
rotating by 45˚. Finally, we have demonstrated that the XY 
plane can identify the direction of electrical activity which is 
TABLE II 
MEAN DIRECTION AND 95% CONFIDENCE INTERVALS OF CARDIAC 
RESYNCHRONIZATION DEVICE SETTINGS IN EACH CARDIOGONIOMETRY PLANE. 
 XY plane (CI) YZ plane (CI) XZ plane (CI) 
No pacing -21 (-2813) -156 (-173-138) -7 (-2411) 
RV pacing -51 (-61-40) -175 (174-164) -8 (-203) 
LV pacing 169 (126-147) 16 (-162178) 149 (-1-62) 
BIV pacing -104 (-147-61) -170 (150-138) -78 (16242) 
Continuous data are expressed as mean and 95% confidence interval.  
Abbreviations: biventricular pacing (BIV); confidence interval (CI); left 
ventricular pacing (LV); right ventricular pacing (RV). 
 
TABLE III 
P VALUES CALCULATED FOR MEAN DIFFERENCES FOR CARDIAC AXIS BETWEEN 
DEVICE SETTINGS; NO PACING VS. RIGHT VENTRICULAR, LEFT VENTRICULAR 
AND BIVENTRICULAR PACING FOR EACH CARDIOGONIOMETRY PLANE. 
 XY plane  YZ plane  XZ plane  
None vs. RV 0.0001 0.410 0.356 
None vs. LV 0.0001 0.005 0.010 
None vs. BIV  0.0001 0.118 0.001 
Abbreviations: biventricular pacing (BIV); left ventricular pacing (LV); right 
ventricular pacing (RV). 
 
Fig. 3. (above) Circular scatter plot demonstrating individual study 
participants’ cardiac axes with no pacing, right ventricular (RV) pacing, left 
ventricular (LV) pacing, and biventricular (BIV) pacing. Black arrows 
represent cardiac axis on CGM YZ plane, red arrows represent cardiac axis 
on 12 lead ECG frontal plane.  
Fig. 4. Circular scatter plots showing the direction of cardiac axis of patients 
with ‘optimal’ paced QRS morphology (red arrows) vs. ‘non-optimal’ paced 
QRS morphology (black arrows) in each CGM plane: XY plane (left), YZ 
plane (centre), XZ plane (right). P value for statistical difference between 
optimal and non-optimal paced QRS morphology shown below each plot. 
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associated with an “optimal” paced QRS morphology.  
In our study, the direction of axis in the XY plane 
corresponded to what might be expected on theoretical grounds. 
RV pacing causes the heart to depolarize from the apex of the 
RV and depolarization therefore moves basally. We found that 
QRS axis during RV pacing was directed posteriorly and 
towards the left base of the heart.  LV pacing causes the heart 
to depolarize from the LV free wall, and therefore the 
depolarization is directed anteriorly towards the RV: the pattern 
we found. During BIV pacing, the direction of electrical activity 
varies depending on the timing delays and location of the LV 
and RV leads. Nevertheless, the overall cardiac depolarization 
during BIV pacing should be directed basally. We found that 
during BIV pacing the QRS axis was directed towards the right 
basal side of the heart (with some variation in overall direction). 
The XY plane, oriented along the long axis of the heart, 
includes large parts of both RV and LV, which may explain why 
recordings in this plane were significantly different between 
each of the pacing modes. Although the YZ (frontal) plane is 
aligned to the long axis of the heart to some degree, the section 
it takes through the heart predominately contains LV, and 
therefore is a poor representation of biventricular electrical 
activity. The XZ plane contains similar amounts of both RV and 
LV is orientated to the short axis of the ventricles and therefore 
does not reflect depolarization from apex to base, but rather 
relates to depolarization from the endocardium to epicardium.  
Depolarization in the XY plane also better discriminated 
between “optimal” CRT delivery and sub-optimal. Of course, 
the definition of “optimal” is to some degree arbitrary and based 
on analysis of 12 lead ECGs. It might be that CGM provides 
additional information which may prove more helpful, 
especially if an ‘optimal’ range of paced QRS axis can be 
determined.  
The trigonometric construction of the CGM YZ and the 
frontal ECG planes both take a coronal slice through the heart: 
and, not surprisingly, previous reports have suggested that the 
two are equivalent [4]. However, we have demonstrated that the 
two are not the same. A possible explanation is that the 
reference points for the CGM and the 12-lead ECG are different 
as CGM does not use Wilson’s central terminal. Furthermore, 
the construction of the CGM YZ plane is fundamentally 
different: it uses information from an electrode on the back 
(electrode 2) which is not used in the 12-lead ECG.  
Whether CGM has anything to offer in clinical practice needs 
to be tested further. Does pacing from different points on a 
multipolar LV lead alter the CGM readings? One potential 
study would be to relate CGM findings to clinical response to 
CRT in a larger sample of patients .using, say, a 6-minute walk 
test, a disease-specific quality of life score and left ventricular 
end systolic volume. Is there a relation between CGM variables 
and “response”? A randomised study might then explore 
whether there is any clinical benefit to manipulating pacing 
sequences based on their effect on CGM variables.  
 
A – Study Limitations 
 
The sample size of the study was small. However, the study 
was designed as a pilot and the fact we were able to demonstrate 
statistically significant differences suggests CGM may have a 
role in assessing CRT delivery. Cardiac axes for both CGM and 
ECG were calculated by hand which could bring a degree of 
human error. Participants had different CRT devices with 
different atrioventricular and interventricular programmed 
settings and the devices and had been implanted at different 
time-points. In particular we did not standardize the 
paced/sensed atrioventricular delay, which has previously been 
shown to affect axis direction [9]. In addition, there may have 
been differences in LV pacing site depending on each 
individual’s coronary venous anatomy. We did not have data on 
the extent and localization of myocardial scar, which may have 
impacted on axes measurements. In addition, native and paced 
electrical axes may change over time. 
We did not measure other cardiogoniometric variables such 
as QRS area within the vector loops for different pacing settings 
which might provide useful information. QRS area assessed by 
VCG predicts response to CRT [8][16]. In addition to this, we 
only looked at direction of the axis of ventricular 
depolarization, and information may be gained from the axes of 
atrial depolarization and ventricular repolarization [17]. 
V. CONCLUSION 
 
CGM can detect differences between ventricular pacing sites. 
It is able to identify patients with a paced QRS morphology 
associated with improvement in clinical endpoints. CGM 
should further be evaluated to explore whether CGM-derived 
axes might help guide CRT lead placement and pacing timing 
intervals to improve patient outcomes.   
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